Financhill
Back

Addex Therapeutics 10K Form

Buy
57

ADXN
Addex Therapeutics

Last Price:
$9.38
Seasonality Move:
-1.43%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ADXN News And Ratings

See the #1 stock for the next 7 days that we like better than ADXN

ADXN Financial Statistics

Sales & Book Value

Annual Sales: $459.1K
Cash Flow: $-665.6K
Price / Cash Flow: 0
Annual Sales: $8.81
Price / Book: 1.08

Profitability

EPS (TTM): 5.13940
Net Income (TTM): $9.5M
Gross Margin: $2.6M
Return on Equity: 91.08%
Return on Assets: 62.62%

Addex Therapeutics Earnings Forecast

Key Addex Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 8 years for ADXN is 91.70%.
  • The Selling, General & Administrative Expenses for ADXN have been equal to 414.55% of Gross Profit Margin.
  • The Research & Development expenses have been 107.69% of Revenue.
  • The Interest Expense is 0.05% of Operating Income.
  • The Net Earning history of ADXN is 1,746.05% of Total Revenues.
  • Per Share Earnings over the last 19 years have been positive in 14 years.

Addex Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ADXN
Website: addextherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 4.59
Quick Ratio: 4.36

Price-to-Earnings

Trailing P/E Ratio: 0.99
Forward P/E Ratio: 0

ADXN Technical Analysis vs Fundamental Analysis

Buy
57
Addex Therapeutics (ADXN) is a Buy

Is Addex Therapeutics a Buy or a Sell?